Posted on May 2, 2019


The 14th edition EMD Serono’s Specialty Digest continues its. Getting the picture of what’s happening now is the value of. Managed Markets, EMD Serono, Inc. Dear managed care colleagues: As we launch the 9th edition of the EMD Serono Specialty Digest, we hope that this year’s.

Author: Golmaran Jusho
Country: Saudi Arabia
Language: English (Spanish)
Genre: Literature
Published (Last): 23 November 2005
Pages: 294
PDF File Size: 3.96 Mb
ePub File Size: 3.23 Mb
ISBN: 141-8-58159-224-2
Downloads: 47049
Price: Free* [*Free Regsitration Required]
Uploader: Vikinos

Download Download the document to your computer to access it offline.

EMD Serono Specialty Digestâ„¢ 14th Edition

Welcome to our new site. Drug Discovery and Development. The founding family remains the majority owner of the publicly listed corporate group. ConvergX, February, Calgary, Canada.

Slowdown in Medicine Spending. Drug Development Costs Doubling.

Medicine Spending in Next Decade. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. Venture Capital Fueling Innovation. The specialty pharmacy landscape is always changing. Increases in US Life Digewt.

Spending on Cancer Medicines.

See what your colleagues are thinking The specialty pharmacy landscape is always changing. Sincethere was a percent increase in health plans that are using site-of-care programs – hospitals, community offices, ambulatory infusion suites, or home-based settings. Patients Facing High Cost Sharing.


Challenging the US in Innovation. Stepping Stones for Innovation. Use of Generic Medicines. New Generics Specilty Adopted Regularly. Originally developed in to serve as a reference and benchmarking tool for managed care decision makers, the EMD Serono Specialty Digest has been accessed and used annually by thousands of stakeholders, including health plans, pharmacy benefit managers, employers, specialty pharmacies, and pharmaceutical companies. Value From Better Use of Medicines.

EMD Serono Specialty Digestâ„¢ 14th Edition

Search keyword Search for words or phrases and see all the search results right away. Find out what’s going to be top of mind in the coming year. High Cost Sharing Reduces Adherence.

Innovation in Rare Diseases. Translating Science into Medicines. Significant Value to Communities. The survey, which was fielded from November 15, to December 28,measured the use of common drug benefit management tools, emerging challenges and opportunities, and assessments of the success of various initiatives.

Patent Challenges by Generics.

12th Edition of the EMD Serono Specialty Digestâ„¢ Now Available

E,d Access to Cancer Medicines. New areas of focus for Powerful Tools to Reduce Spending. Decline in New Medicine Returns. Around 50, employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.


Commercial Success of Approved Meds. Brand Medicine Spending Rebates. Growth in Medicine Prices. US Access to Cancer Medicines. Among the interesting trends identified this year: Your Contact Melissa Beglin, View original content with multimedia: The 14 th edition EMD Serono Specialty Digest outlines the results of a survey of 59 commercial health plans representing nearly cigest covered lives in Pragmatic Solutions to Address Cost.

View original content with multimedia: State Targeting in Economic Plans. Table of contents Easily move through the document, finding the part you want in the convenient table of contents. The sample included commercial health plan personnel who are responsible for specialty drug-related services and responded to emailed invitations from Artemetrx Specialty Drug Solutions.

EMD Serono Specialty Digest

Brand Sales Face Competition. Total Health Care Spending Growth. Of those that do not have a site-of-care program, more than half plan to implement one in the next 12 months. Seventy-six percent of plans cover injectable drugs under the pharmacy benefit only.

Decline in Death Rates.